5-甲基-2-(2,4,6-三氟苯基)-2H-吡唑-3-胺 | 106259-87-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-甲基-2-(2,4,6-三氟苯基)-2H-吡唑-3-胺
• 中文别名: 5-氨基-3-甲基-1-(2,4,6-三氯苯基)吡唑
• 英文名称: 5-Amino-3-methyl-1-(2,4,6-trichlorophenyl)-pyrazol
• 英文别名: 5-amino-3-methyl-1-(2,4,6-trichlorophenyl)-pyrazole；3-Amino-2-(2,4,6-trichlorophenyl)-5-methylpyrazole；3-Methyl-1-(2,4,6-trichlorophenyl)-1H-pyrazol-5-amine；5-methyl-2-(2,4,6-trichlorophenyl)pyrazol-3-amine
• CAS: 106259-87-4
• 化学式: C₁₀H₈Cl₃N₃
• mdl: MFCD03093785
• 分子量: 276.553
• InChiKey: ABLOGSPAFQBNMG-UHFFFAOYSA-N

物化性质

• 沸点：
  419.2±45.0 °C(Predicted)
• 密度：
  1.57±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  43.8
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933199090

反应信息

• 作为反应物：
  描述：

  5-甲基-2-(2,4,6-三氟苯基)-2H-吡唑-3-胺 在 N-碘代丁二酰亚胺 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成 5-Amino-4-iodo-3-methyl-1-(2,4,6-trichlorophenyl)pyrazole
  参考文献：
  名称：

  US6075043

  摘要：

  公开号：
• 作为产物：
  描述：

  ethyl 5-amino-3-methyl-1-(2,4,6-trichlorophenyl)-pyrazol-4-ylcarboxylate 以 水 、 异丙醇 为溶剂， 生成 5-甲基-2-(2,4,6-三氟苯基)-2H-吡唑-3-胺
  参考文献：
  名称：

  1-aryl-4-alkylthiopyrazol-5-amine derivatives, composition containing

  摘要：

  一种对抗昆虫、感知动物和线虫的方法，包括向昆虫、蜘蛛、线虫和/或它们的环境施加至少一种式(I)的有效量的5-氨基吡唑化合物，其中R.sup.1代表氢、烷基或卤代烷基，R.sup.2代表烷基、卤代烷基、未取代或取代的芳基烷基或未取代或取代的芳基，R.sup.3代表氢、烷基或基团，Ar代表未取代或取代的苯基或未取代或取代的吡啶基，n代表数字0、1或2，其中X代表氧或硫，R.sup.4代表氢、烷基、烯烷基、炔烷基、卤代烷基、烷氧基烷基、烷基硫基烷基、未取代或取代的环烷基、未取代或取代的芳基、烷氧基、烷基硫基、未取代或取代的芳氧基、未取代或取代的芳硫基、烷基氨基、二烷基氨基或未取代或取代的芳基氨基。

  公开号：

  US04804675A1

文献信息

• Pest-combating agents based on pyrazole derivatives
  申请人：Bayer Aktiengesellschaft

  公开号：US04945165A1

  公开（公告）日：1990-07-31

  A 5-aminopyrazole of the formula (I) ##STR1## in which R.sup.2 represents CF.sub.3 or CCL.sub.2 F, R.sup.3 represents hydrogen or CH.sub.3 and n represents the number 0 or 1. The 5-aminopyrazole of formula (I) is effective in combating insects, sense animals and nematodes.

  式(I)的5-氨基吡唑##STR1##其中R.sup.2代表CF.sub.3或CCL.sub.2 F，R.sup.3代表氢或CH.sub.3，n代表数字0或1。式(I)的5-氨基吡唑对抗昆虫、感官动物和线虫有效。
• Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
  申请人：——

  公开号：US20030078277A1

  公开（公告）日：2003-04-24

  The present invention provides a novel compound having an excellent corticotrophin-releasing-factor receptor antagonistic activity. That is, it provides a compound represented by the following formula, a pharmacologically acceptable salt thereof or hydrates thereof. 1 Wherein A, B and D are the same as or different from each other and each represents a group represented by the formula —(CR 1 R 2 ) m — (wherein R 1 and R 2 are the same as or different from each other and each represents a C 1-6 alkyl group etc.), —NR 3 — (wherein R 3 represetns hydrogen etc.) etc.; E and G are the same as or different from each other and each represents a group represented by the formula —(CR 6 R 7 ) p — (wherein R 6 and R 7 are the same as or different from each other and each represents hydrogen etc.; and p represents an integer of 0, 1 or 2); J represents a carbon atom or nitrogen atom, each substituted with C 1-6 alkyl group optionally substituted with a halogen atom, etc.; K and L are the same as or different from each other and each represents carbon atom or nitrogen atom; M means hydrogen, a halogen atom, an optionally substituted C 1-6 alkyl group etc.; and the partial structure means a single or double bond.

  本发明提供了一种具有优异的促肾上腺皮质激素释放因子受体拮抗活性的新化合物。即提供了由以下公式表示的化合物，其药理学上可接受的盐或水合物。其中A、B和D相互相同或不同，每个代表以下公式表示的基团：—(CR1R2)m—（其中R1和R2相互相同或不同，每个代表C1-6烷基等），—NR3—（其中R3代表氢等）等；E和G相互相同或不同，每个代表以下公式表示的基团：—(CR6R7)p—（其中R6和R7相互相同或不同，每个代表氢等；p代表0、1或2的整数）；J代表一个碳原子或氮原子，每个都被C1-6烷基等可选择地取代的卤素原子等取代；K和L相互相同或不同，每个代表碳原子或氮原子；M代表氢、卤素原子、可选择地取代的C1-6烷基等；部分结构表示单键或双键。
• PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY
  申请人：——

  公开号：US20020016333A1

  公开（公告）日：2002-02-07

  The pyrazoles and pyrazolopyrimidines of the formula 1 wherein R 1 , R 2 , R 3 , R 4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.

  式1中的吡唑和吡唑嘧啶，其中R1、R2、R3、R4和A的定义如本文所述，具有促肾上腺皮质释放因子（CRF）拮抗活性。因此，它们在治疗包括与压力相关的疾病在内的广泛疾病中是有效的。
• Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
  申请人：Pfizer Inc.

  公开号：US05712303A1

  公开（公告）日：1998-01-27

  The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.

  公式为##STR1##中的吡唑和吡唑吡嘧啶，其中R.sub.1、R.sub.2、R.sub.3、R.sub.4和A的定义如本文所述，具有促肾上腺皮质激素释放因子（CRF）拮抗剂活性。因此，它们在治疗包括与压力相关的疾病在内的广泛疾病方面是有效的。
• Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
  申请人：Hibi Shigeki

  公开号：US20050004159A1

  公开（公告）日：2005-01-06

  The present invention provides a novel compound having an excellent corticotrophin-releasing-factor receptor antagonistic activity. That is, it provides a compound represented by the following formula, a pharmacologically acceptable salt thereof or hydrates thereof. Wherein A, B and D are the same as or different from each other and each represents a group represented by the formula —(CR 1 R 2 ) m — (wherein R 1 and R 2 are the same as or different from each other and each represents a C 1-6 alkyl group etc.), —NR 3 — (wherein R 3 represetns hydrogen etc.) etc.; E and G are the same as or different from each other and each represents a group represented by the formula —(CR 6 R 7 ) p — (wherein R 6 and R 7 are the same as or different from each other and each represents hydrogen etc.; and p represents an integer of 0, 1 or 2); J represents a carbon atom or nitrogen atom, each substituted with C 1-6 alkyl group optionally substituted with a halogen atom, etc.; K and L are the same as or different from each other and each represents carbon atom or nitrogen atom; M means hydrogen, a halogen atom, an optionally substituted C 1-6 alkyl group etc.; and the partial structure means a single or double bond.

  本发明提供了一种具有优异的促肾上腺皮质激素释放因子受体拮抗活性的新化合物。即，本发明提供了由以下式表示的化合物，其药学上可接受的盐或水合物。其中，A、B和D相同或不同，每个代表由公式—（CR1R2）m—（其中R1和R2相同或不同，每个代表C1-6烷基等）、—NR3—（其中R3表示氢等）等表示的基团；E和G相同或不同，每个代表由公式—（CR6R7）p—（其中R6和R7相同或不同，每个代表氢等；p表示0、1或2的整数）表示的基团；J代表一个碳原子或氮原子，每个用C1-6烷基取代，可选择用卤原子等取代；K和L相同或不同，每个代表碳原子或氮原子；M表示氢、卤原子、可选择用取代的C1-6烷基等取代；而部分结构表示单键或双键。